Dr. Paul S. Anderson Based on known data regarding MDS and its etiology as well as potential therapies (see below) there is a low probability of ‘cure’ using known therapies. Supportive care is the mainstay of therapy especially in patients over 60 years of age. Oxidative treatments are indicated, as well as transplantation, growth factors, …
This appeared originally in the August-September issue of the Townsend Letter, 2018 It outlines the evolution of, a case series using and the actual protocols we now employ in our integrative metabolic cancer therapy.
Originally aired on 03-22-2018 In this show we will discuss what they are and how they are used in the body. Why do we need to supplement (or do we)? When would I need them most? What categories are there and what are safe doses? When can I take more to help with a …
QUESTION: 60 yo male – Medical history: Parkinson’s plus syndrome (suspicion for PSP type), type II diabetes, HTN. Current Rx metformin, Invokana, Monopril, Sinemet, LDN Current symptoms include bradykinesia, ataxia, dysarthria, widened gait that is unbalanced, cognitive impairment (subjective and observed complaints of recall and confusion) however MOCA score continues to be WNL. He is no longer …
THERAPEUTIC OPTIONS FOR PROGRESSING PARKINSON’S CONT Read More »
QUESTION: Can I use Poly-MVA in children? If so, how would I dose it? ANSWER: We have used Poly-MVA in all ages, and used it in quite small (under 20 lb) children. Dosing depends on indication, and for cancer we tend to dose higher and in autoimmunity lower. I have our clinic dose adjustment below. …
QUESTION: I have a patient with fluoroquinolone toxicity. She was referred to me by a chiropractic neurologist for glutathione infusions. She has not responded particularly well to that approach, so if you could please share your perspective, I would again be most appreciative. She is also finding mixed info about whether or not the Cipro remains in …
MY QUESTIONS ARE: I have a patient with MS and am wondering what things I should include in my assessment and care plans. ANSWERS: We generally try to consider multiple potential aggravations in the patient which can increase the effect and symptom picture in MS and other autoimmune cases. These include immunologic, infectious, inflammatory, toxic …
MULTIPLE SCLEROSIS AUTOIMMUNITY AND CLINICAL Cont. Read More »
